Douglas French - Profile and Investment Details

Investor Profile

Douglas French is a Venture Capital, Private Equity Firm, Investor based in Austin, Texas, United States with a diverse investment portfolio that includes companies such as HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics, Claret Medical, Iterion Therapeutics, Zeno Corporation, Terapio, RiseHealth, Rex Bionics, Renascent Medical, Lumos Pharma, Explorys, Protein Discovery, Guided Interventions, Farapulse, LumaThermGeneos Therapeutics, TVA Medical, kēlaHealth, Spinal Restoration, DyaMX, BioStable, Cryosa, Lyric Pharmaceuticals, BAROnova, Millipede, Molecular Templates, Mirna Therapeutics, AbVitro, Remedy, Libra Therapeutics, EndoStim, Glyscend, Laguna Pharmaceuticals, . Over time, Douglas French has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Douglas French is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Hospitals, Wellness, Women Founded, Outpatient Care, Information Services, Information Technology (IT), Software, Biotechnology, Hispanic / Latinx Founded, Productivity Software, Landscaping, Clinical Trials, Health Diagnostics, Medical, Therapeutics, Media and Entertainment, Cosmetic Surgery, Pharmaceuticals may find it worthwhile to explore potential connections with Douglas French, as their portfolio suggests a familiarity and interest in this area.

Understanding Douglas French’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.